European Biotech Acquisition Corp. Warrant
EBACW
EBACW was delisted on the 2nd of March, 2023.
30 hedge funds and large institutions have $932K invested in European Biotech Acquisition Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
42% less capital invested
Capital invested by funds: $1.61M → $932K (-$681K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$23.4K |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$9.14K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$5.32K |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$4.46K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$467 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMH
Apollo Management Holdings
New York
|
-$20K |
| 2 |
CCM
CAAS Capital Management
New York
|
-$20K |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$14.5K |
| 4 |
SAMU
SONA Asset Management (US)
New York
|
-$4K |
| 5 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$1.82K |
EBACW Hedge Fund Activity: Q1 2022 in Review
30 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q1 2022, worth a combined $932K — down 42% from $1.61M a quarter earlier.
Fund positioning in EBACW was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Picton Mahoney Asset Management, adding an estimated $23.4K. The largest seller was Apollo Management Holdings, exiting entirely with an estimated $20K sold.
- 30 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $932K of European Biotech Acquisition Corp. Warrant stock for Q1 2022, down 42% quarter-over-quarter.
- 3 funds opened new European Biotech Acquisition Corp. Warrant positions in Q1 2022 and 3 closed out, a net change of 0 holders.
- The largest European Biotech Acquisition Corp. Warrant buyer in Q1 2022 was Picton Mahoney Asset Management, an estimated $23.4K added.
- The largest European Biotech Acquisition Corp. Warrant seller in Q1 2022 was Apollo Management Holdings, an estimated $20K sold.
Based on aggregated 13F filings for Q1 2022.